发明名称 MIC-1 fusion proteins and uses thereof
摘要 The invention relates to MIC-1 fusion proteins. More specifically it relates to compounds comprising fusion proteins comprising a MIC-1 protein or an analog thereof at the C-terminus of the fusion protein and a functional variant of human serum albumin at the N-terminus of the fusion protein connected via a peptide linker. The compounds of the invention have MIC-1 activity. The invention also relates to pharmaceutical compositions comprising such compounds and pharmaceutically acceptable excipients, as well as the medical use of the compounds.
申请公布号 US9272019(B2) 申请公布日期 2016.03.01
申请号 US201514742159 申请日期 2015.06.17
申请人 Novo Nordisk A/S 发明人 Shaw Allan Christian;Helgstrand Charlotte;Sandrini Michael Paolo Bastner;Joergensen Sebastian Beck;Thoegersen Henning;Sass-Oerum Kristian;Hastrup Sven;Andersen Kim Vilbour
分类号 A61K38/19;C07K14/765;C07K14/52;C07K14/00;A61K38/38 主分类号 A61K38/19
代理机构 代理人 Lum Leon Y.
主权项 1. A fusion protein of formula (I): A-B—C  (I), wherein A is human serum albumin or a functional variant thereof; B is a peptide linker having the amino acid sequence of SEQ ID NO:9; and C is a MIC-1 protein or an analogue thereof, wherein the C-terminus of the human serum albumin or functional variant thereof is fused to the N-terminus of the peptide linker, and wherein the C-terminus of the peptide linker is fused to the N-terminus of the MIC-1 protein or analogue thereof.
地址 Bagsvaerd DK